Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases
Pin‐Nan Cheng, Wen‐Jone Chen, Charles Jia‐Yin Hou, et al.
Clinical and Molecular Hepatology (2023) Vol. 30, Iss. 1, pp. 16-36
Open Access | Times Cited: 10

Showing 10 citing articles:

Metabolic dysfunction‐associated steatotic liver disease is associated with increased risks of heart failure
Kai‐Chun Chang, Tung‐Hung Su, Cho‐Kai Wu, et al.
European Journal of Heart Failure (2025)
Closed Access | Times Cited: 5
A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
Moon Haeng Hur, Terry Cheuk‐Fung Yip, Seung Up Kim, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 6
Fatty Liver and Hyperuricemia in Workers: Combined Effects on Metabolic Dysfunction and the Role of Lifestyle Factors
Jui‐Hua Huang, Ren-Hau Li, Hon‐Ke Sia, et al.
Metabolites (2025) Vol. 15, Iss. 5, pp. 318-318
Open Access
Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
Pin‐Nan Cheng, Ming‐Lung Yu
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 144-146
Open Access | Times Cited: 2
High sensitivity troponins and mortality in the population with metabolic dysfunction-associated steatotic liver disease
Jingjing Hu, Yuteng Du, Yidan Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
MASLD: an emerging factor in the pathophysiology and clinical management of ICC
Zong‐Long Li, Jia-Lu Chen, Yue Tang, et al.
Hepatoma Research (2024)
Open Access | Times Cited: 2
The unfolded features on the synchronized fashion of gut microbiota and Drynaria rhizome against obesity via integrated pharmacology
Ki‐Kwang Oh, Sang Jun Yoon, Seol Hee Song, et al.
Food Chemistry (2024) Vol. 460, pp. 140616-140616
Open Access | Times Cited: 1
Metabolic dysfunction-associated fatty liver disease: bridging cardiology and hepatology
Xiaodong Zhou, Giovanni Targher, Christopher D. Byrne, et al.
Cardiology Plus (2024)
Open Access | Times Cited: 1
Effect of metabolic dysfunction on the risk of liver-related events in patients cured of hepatitis C virus
Wei‐Fan Hsu, Hsueh‐Chou Lai, Sheng‐Hung Chen, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 4, pp. 1914-1925
Open Access | Times Cited: 1
Reply to “A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B: Is cirrhosis driving the performance?”
Moon Haeng Hur, Jeong‐Hoon Lee
Journal of Hepatology (2024)
Closed Access
MAFLD: from a disease framework to patient care
Mohammed Eslam, Jacob George
Hepatology International (2024)
Open Access
Page 1

Scroll to top